You may also like
FDA Issues Public Health Advisory for Trasylol
The Food and Drug Administration today issued a Public Health Advisory alerting doctors who perform heart bypass surgery, and their patients, that Trasyolol (aprotinin injection), a drug used to prevent blood loss during surgery, has been linked in two scientific publications to higher risks of serious side effects including kidney problems, heart attacks and strokes in patients who undergo artery bypass graft surgery.
2 min read
Large Volume Infusions of Hydroxyethyl Starch During Cardiothoracic Surgery May Be Associated With Postoperative Kidney Injury: Propensity-Matched Analysis
Intraoperative use of HES was not associated with postoperative AKI following CPB.
1 min read
VV ECMO Strategies for COVID-19, A Single Center Experience
Topics covered in this webinar included patient selection and management, cannulation preference, extracorporeal circuit design, staffing models and personal protective equipment.
1 min read